diabetes. non-insulin-dependent
Conditions
Interventions
Intervention 1: 2 Omega3 capsules a day (1000 mg oil include 360 mg EPA and 240 mg DHA). Intervention 2: 2 Placebo Capsules a day (1gr corn starch).
Prevention
Placebo
2 Omega3 capsules a day (1000 mg oil include 360 mg EPA and 240 mg DHA)
2 Placebo Capsules a day (1gr corn starch)
Sponsors
Tehran Medical Sience University
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: type II diabetic women with at least five years past from their diagnosis; women who were volunteers for participating in the study. Exclusion criteria: insulin injection, secondary complications of diabetes such as ophthalmic and renal complication, amputation, diseases caused by diabetes complications such as kidney disease, amputation, blindness, heart diseases, and inflammatory disease in which CPR level was +++ or more.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visfatin. Timepoint: befor and after trial. Method of measurement: special Lab kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| TG. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;HbA1c. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;Cholestrol. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;FBS. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;HDL. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;LDL. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Hajianfar
Tehran University of Medical Sciences
Outcome results
None listed